This page shows the details of why an item matched the keywords from your search.
Property | Value |
has major subject area list
|
Antibodies, Monoclonal; Anticholesteremic Agents; Blood Component Removal; Hyperlipoproteinemia Type II
|
information resource reference
|
Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study. Lancet Diabetes Endocrinol. 2017 04; 5(4):280-290.
|
label
|
Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study.
|